Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amantadine for Chorea in Huntington's Disease
NCT00001930Phase 2Completed
- Sponsor
- National Institute of Neurological Disorders and Stroke
- Start
- Apr 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Huntington's disease (HD) comparing Amantadine with Placebo (2 arms). Primary endpoint: Unified Huntington's Disease Rating Scale (UHDRS) Chorea Score at 2 weeks. Started Apr 1999; status: completed.
02
Drugs
amantadine
03
Conditions
Huntington's disease (HD)
Beyond the preview
Go deeper on NCT00001930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001930.